RxDoctor Payments Data

Shannon Spina

Psychiatric/Mental Health · Syracuse, NYNPI 1174937361

Payments from drug & device makers

$1,400in general payments, 2019–2025

Across 86 payments — averaging $16.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$305
  • Alkermes, Inc.$173
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$116
  • Teva Pharmaceuticals USA, Inc.$110
  • Johnson & Johnson$102
  • Vanda Pharmaceuticals Inc.$97
  • plus $496 from 10 others

What the payments were for

  • Food & beverage$1,35397%
  • Education$473%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,400 in reported general payments places this provider in the 70th percentile of 2,385 psychiatric/mental health providers in New York.

See all psychiatric/mental health providers in New York

Medicare billing

Part B allowed, 2024
$7,664
Medicare patients
17
Services billed
91

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate19$66,721
Abilify MaintenaAripiprazole13$37,846
Lurasidone Hcl38$24,424
RexultiBrexpiprazole17$23,597
PristiqDesvenlafaxine Succinate11$9,151
Quetiapine Fumarate ErQuetiapine Fumarate12$4,870
Desvenlafaxine Succinate ErDesvenlafaxine Succinate38$3,624
AdderallDextroamphetamine/Amphetamine11$3,390
Aripiprazole53$3,291
Duloxetine Hcl53$2,516
Adderall XrDextroamphetamine/Amphetamine11$2,253
Bupropion XlBupropion Hcl60$1,636
Quetiapine Fumarate58$1,462
Clonazepam83$1,281
Hydroxyzine Hcl41$798

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$102$66,72119 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti$73$61,44330 claims
Takeda Pharmaceuticals U.S.A., Inc.Adderall$29$3,39011 claims
Almatica Pharma LLCSertraline Hcl$13$17060 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 2,385 psychiatric/mental health providers in New York.

Other psychiatric/mental health in Syracuse

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →